Genmab Email Format

Biotechnology Research
1,001-2,500 employees
Copenhagen, Denmark

Genmab is a Danish biotechnology company dedicated to developing innovative antibody-based medicines for cancer and other serious diseases, with operations across North America, Europe, and Asia Pacific.

Find contacts at Genmab

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstinitiallast@genmab.com

Company Overview

Industry
Biotechnology Research
Founded
1999
Headquarters
Copenhagen, Denmark
Revenue
$2.5B-$5B
FUNDING Stage
Public
Key Executives
Jan G. J. van de Winkel (President & Chief Executive Officer), Anthony Pagano (Executive Vice President and Chief Financial Officer), Rayne Waller (Executive Vice President and Chief Technical Operations Officer)

Tech Stack

Databricks

Analytics

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Genmab?

Genmab uses the firstinitiallast format, so Jane Smith would be jsmith@genmab.com.

What proprietary antibody technology platforms has Genmab developed?

Genmab has built several proprietary platforms, including DuoBody for bispecific antibodies and HexaBody for enhanced potency therapeutics. These platforms underpin both its own pipeline and a range of partnerships with companies like Janssen, AbbVie, and BioNTech.

How many employees does Genmab have and where are its main offices?

Genmab has around 2,861 employees. The company is headquartered in Copenhagen, Denmark, with major offices in Plainsboro, New Jersey, Utrecht in the Netherlands, Tokyo, Munich, and Suzhou.

Which approved medicines include Genmab science in their development?

Eight approved antibody medicines are powered by Genmab science in 2026, including DARZALEX for multiple myeloma, EPKINLY for B-cell lymphomas, and TIVDAK for recurrent cervical cancer, with royalties and co-commercialization arrangements varying by product.

Can I find specific Genmab contacts or verify a Genmab email address before reaching out?

Tools like Clay let you build and enrich a target list of Genmab contacts, applying the firstinitiallast@genmab.com pattern to verify addresses before outreach. Genmab co-founded its US commercial presence in Plainsboro, New Jersey, so filtering by location can help narrow to the right team.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles